Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Haramburu

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Drug Safety|September 18, 2007
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety biasAntoine Pariente, Fleur Gregoire, Annie Fourrier-Reglat, et al.
Drug Safety|March 4, 2020
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score StrategiesRomain Demailly, Sylvie Escolano, Françoise Haramburu, et al.
Therapie|April 11, 2015
Signal identification in addictovigilance: the functioning of the French systemEmilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, et al.
Drug Safety|April 13, 2013
Pharmacovigilance systems in developing countries: an evaluative case study in Burkina FasoLassane Kabore, Pascal Millet, Souleymane Fofana, et al.
BMC Medical Research Methodology|February 5, 2014
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databasesFanny Leroy, Jean-Yves Dauxois, Hélène Théophile, et al.
Fundamental & Clinical Pharmacology|September 2, 2016
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM surveyAmélie Daveluy, Elisabeth Frauger, Hélène Peyrière, et al.
Therapie|September 9, 2018
[From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)]Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, et al.
Therapie|September 18, 2014
Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa)Amélie Daveluy, Hélène Géniaux, Lucile Thibaud, et al.
European Journal of Clinical Pharmacology|May 21, 2011
Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administrationHélène Théophile, Ghada Miremont-Salamé, Philip Robinson, et al.
Journal of Clinical Epidemiology|August 23, 2012
An updated method improved the assessment of adverse drug reaction in routine pharmacovigilanceHélène Théophile, Manon André, Yannick Arimone, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Drug Safety|September 18, 2007
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety biasAntoine Pariente, Fleur Gregoire, Annie Fourrier-Reglat, et al.
Drug Safety|March 4, 2020
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score StrategiesRomain Demailly, Sylvie Escolano, Françoise Haramburu, et al.
Therapie|April 11, 2015
Signal identification in addictovigilance: the functioning of the French systemEmilie Jouanjus, Valérie Gibaja, Jean-Pierre Kahn, et al.
Drug Safety|April 13, 2013
Pharmacovigilance systems in developing countries: an evaluative case study in Burkina FasoLassane Kabore, Pascal Millet, Souleymane Fofana, et al.
BMC Medical Research Methodology|February 5, 2014
Estimating time-to-onset of adverse drug reactions from spontaneous reporting databasesFanny Leroy, Jean-Yves Dauxois, Hélène Théophile, et al.
Fundamental & Clinical Pharmacology|September 2, 2016
Which psychoactive substances are used by patients seen in the healthcare system in French overseas territories? Results of the OPPIDUM surveyAmélie Daveluy, Elisabeth Frauger, Hélène Peyrière, et al.
Therapie|September 9, 2018
[From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)]Marie Baumevieille, Joëlle Perri-Plandé, Ghada Miremont-Salamé, et al.
Therapie|September 18, 2014
Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa)Amélie Daveluy, Hélène Géniaux, Lucile Thibaud, et al.
European Journal of Clinical Pharmacology|May 21, 2011
Relevance of a "Dear Doctor letter" to alert healthcare providers to new recommendations for vitamin D administrationHélène Théophile, Ghada Miremont-Salamé, Philip Robinson, et al.
Journal of Clinical Epidemiology|August 23, 2012
An updated method improved the assessment of adverse drug reaction in routine pharmacovigilanceHélène Théophile, Manon André, Yannick Arimone, et al.
Pageof 7